Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIOS II: Diuretics Add-On Strategy in ADHF
NCT02047422Phase 2Withdrawn
- Sponsor
- Yonsei University
- Start
- Jan 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of metolazone, spironolactone, furosemide in acute decompensated heart failure (ADHF), sponsored by Yonsei University. Planned start Jan 2014; status: withdrawn.
02
Drugs
metolazonespironolactonefurosemide
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT02047422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047422.